Found 911 matching trials
Radiation Therapy in Unresectable Gall Bladder Cancer PHASE2 The goal of this clinical trial is to compare two treatment regimes, namely...
Show More Location
Tata Memorial Centre
Learn More & Join Trial
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer PHASE2 The goal of this single-arm, Phase II interventional clinical trial is to t...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) PHASE1 GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Targeting ATR in Soft-tissue Sarcomas PHASE2 Multicenter, prospective, open-labeled, 2-arm, non-comparative randomized p...
Show More Location
Institut Bergonié
Learn More & Join Trial
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer PHASE2 This is a prospective, single-arm trial. The main purpose of the study is t...
Show More Location
Zhejiang Provincial People's Hospital
Learn More & Join Trial
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen PHASE2 This is a single arm, open label Phase II clinical trial to evaluate the ef...
Show More Learn More & Join Trial
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer PHASE3 The main purpose of this study is to compare the disease-free survival betw...
Show More Learn More & Join Trial
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer PHASE2 Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC PHASE3 A multicenter randomized controlled study of surgery combined with neoadjuv...
Show More Location
Eye& ENT Hospital, Fudan University
Learn More & Join Trial
Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments PHASE3 Comparison of olaparib vs. physician's choice of single agent standard of c...
Show More Learn More & Join Trial